We operate in a virtual, agile way by sourcing innovations from the Finnish scientific heritage.
Montisera takes full advantage of bioactive molecules. The best assets of Finnish university and research institutes turn into active development projects and business cases; ending into pharmaceuticals along with the bioeconomy-based active molecules and natural products.
MONTISERA STRENGTHENS EXECUTIVE MANAGEMENT TEAM BY APPOINTING NEW CEO
(Montisera, Turku; November 5th, 2019) – Montisera Ltd, a Finnish development company focused on developing and commercializing bioactive compounds, have announced today that it has appointed Jukka Mäkelä as company’s new CEO. At the same time, he has been appointed as CEO of Montisera’s daughter companies Montinutra Ltd and Montipharma Ltd.